End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
34.5 CNY | +5.31% | +6.32% | +5.54% |
May. 24 | Mabwell Announces 9MW2821 Clinical Data | CI |
May. 13 | Mabwell Announces Clinical Trial Progress of 9MW2821 in Triple-Negative Breast Cancer | CI |
Chart: Technical Analysis
- Stock Market
- Equities
- 688062 Stock
- Charts Mabwell (Shanghai) Bioscience Co., Ltd.